Turkish cross-sectional survEy of glycemic and other Metabolic parameters in patients with type 2 Diabetes in 2023: Comparison with 2018 nationwide data (TEMD-2 study)
{{output}}
Aim: Five years after the first "Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with type 2 Diabetes" (TEMD-1), attainment of glycemic, arterial blood pressure (ABP), and LDL-cholesterol (LDL-C... ...
